Background The severity of COVID-19 remains high worldwide. Therefore, millions of
individuals are likely to suffer from fear of COVID-19 and related mental health factors. Aims …

The prevalence of mental health disorders has increased during the COVID-19 pandemic.
Patients with chronic diseases, such as diabetes, are a particularly vulnerable risk group …

Introduction Several studies have shown that COVID-19 pandemic has a negative impact on
type 2 diabetic mellitus (T2DM) patients' quality of life (QoL). However, very few studies were …

Objectives: To assess perceived fear and to evaluate the level of knowledge, attitude, and
prevention practices (KAP) regarding COVID-19 infection among patients with diabetes …

The management of chronic diseases in the midst of the COVID-19 pandemic is especially
challenging, and reducing potential psychological harm is essential. This review aims to …

Chronic dialysis patients have an increased risk of severe COVID-19 infection-related
complications. The aim of this study was to quantify the impact of the COVID-19 pandemic …

Background. Type 2 diabetes mellitus (T2DM) is a global public health challenge. T2DM self‐
management, including diet, physical activity, blood glucose self‐monitoring, foot care, and …

Diabetes mellitus can be a complex disorder described by chronic progressive metabolic
disorder and chronic hyperglycemia arising from dysregulation of carbohydrate, lipid and …

Abstract Background COVID-19's after-effects among survivors are of increased concern.
The cognitive aftermath of COVID-19 virus infection was underrated. This study aimed to …

Inhibition of intestinal α‐glucosidase (αGS), a crucial enzyme in carbohydrate digestion, is
an effective therapeutic approach for diabetes mellitus treatment. The C‐glycosylflavonoids …